CN103601661A - Ⅱ型糖尿病药物格列美脲三光气的合成方法 - Google Patents
Ⅱ型糖尿病药物格列美脲三光气的合成方法 Download PDFInfo
- Publication number
- CN103601661A CN103601661A CN201310431127.4A CN201310431127A CN103601661A CN 103601661 A CN103601661 A CN 103601661A CN 201310431127 A CN201310431127 A CN 201310431127A CN 103601661 A CN103601661 A CN 103601661A
- Authority
- CN
- China
- Prior art keywords
- triphosgene
- synthetic method
- diabetes medicine
- type
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310431127.4A CN103601661B (zh) | 2013-09-22 | 2013-09-22 | Ⅱ型糖尿病药物格列美脲三光气的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310431127.4A CN103601661B (zh) | 2013-09-22 | 2013-09-22 | Ⅱ型糖尿病药物格列美脲三光气的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103601661A true CN103601661A (zh) | 2014-02-26 |
CN103601661B CN103601661B (zh) | 2015-10-21 |
Family
ID=50119945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310431127.4A Expired - Fee Related CN103601661B (zh) | 2013-09-22 | 2013-09-22 | Ⅱ型糖尿病药物格列美脲三光气的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103601661B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106699631A (zh) * | 2017-02-08 | 2017-05-24 | 深圳市新阳唯康科技有限公司 | 一种格列美脲γ晶型及其制备方法 |
CN106866486A (zh) * | 2017-02-08 | 2017-06-20 | 深圳市新阳唯康科技有限公司 | 一种格列美脲α晶型及其制备方法 |
CN107382813A (zh) * | 2017-08-21 | 2017-11-24 | 扬子江药业集团江苏海慈生物药业有限公司 | 格列美脲关键中间体的合成方法 |
CN107400077A (zh) * | 2017-08-24 | 2017-11-28 | 北大医药股份有限公司 | 一种格列美脲的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1109872A (zh) * | 1993-12-30 | 1995-10-11 | 赫彻斯特股份公司 | 取代苯磺酰脲和一硫脲,其制备方法及其药物制剂用途 |
WO2004073585A2 (en) * | 2003-02-21 | 2004-09-02 | Zentiva, A. S. | Methode of manufacturing glimepiride and the respective intermediate |
KR20050017776A (ko) * | 2003-08-08 | 2005-02-23 | 명문제약주식회사 | 글리메피라이드의 제조방법 |
CN101671290A (zh) * | 2009-10-11 | 2010-03-17 | 沧州那瑞化学科技有限公司 | 格列美脲原料药的制备方法 |
-
2013
- 2013-09-22 CN CN201310431127.4A patent/CN103601661B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1109872A (zh) * | 1993-12-30 | 1995-10-11 | 赫彻斯特股份公司 | 取代苯磺酰脲和一硫脲,其制备方法及其药物制剂用途 |
WO2004073585A2 (en) * | 2003-02-21 | 2004-09-02 | Zentiva, A. S. | Methode of manufacturing glimepiride and the respective intermediate |
KR20050017776A (ko) * | 2003-08-08 | 2005-02-23 | 명문제약주식회사 | 글리메피라이드의 제조방법 |
CN101671290A (zh) * | 2009-10-11 | 2010-03-17 | 沧州那瑞化学科技有限公司 | 格列美脲原料药的制备方法 |
Non-Patent Citations (2)
Title |
---|
刘占科等: "三光气法合成降糖药格列美脲", 《精细化工中间体》, no. 03, 30 August 2006 (2006-08-30) * |
邓勇等: "降血糖新药――格列美脲合成工艺研究", 《中国药物化学杂志》, no. 02, 20 June 2000 (2000-06-20) * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106699631A (zh) * | 2017-02-08 | 2017-05-24 | 深圳市新阳唯康科技有限公司 | 一种格列美脲γ晶型及其制备方法 |
CN106866486A (zh) * | 2017-02-08 | 2017-06-20 | 深圳市新阳唯康科技有限公司 | 一种格列美脲α晶型及其制备方法 |
CN107382813A (zh) * | 2017-08-21 | 2017-11-24 | 扬子江药业集团江苏海慈生物药业有限公司 | 格列美脲关键中间体的合成方法 |
CN107382813B (zh) * | 2017-08-21 | 2019-12-17 | 扬子江药业集团江苏海慈生物药业有限公司 | 格列美脲关键中间体的合成方法 |
CN107400077A (zh) * | 2017-08-24 | 2017-11-28 | 北大医药股份有限公司 | 一种格列美脲的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103601661B (zh) | 2015-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103601661A (zh) | Ⅱ型糖尿病药物格列美脲三光气的合成方法 | |
CN111285829B (zh) | 一类PPARγ/δ双重激动剂、其制备方法及其作为药物的用途 | |
CN101143863B (zh) | 5-甲基四氢叶酸的拆分及其成盐方法 | |
CN102584795B (zh) | 一种克里唑替尼的制备方法 | |
CN103420891B (zh) | Ⅱ型糖尿病药物格列美脲中间体苯磺胺三光气的合成方法 | |
AU2014282281A1 (en) | Stable crystal form of tipiracil hydrochloride and crystallization method for the same | |
CN103044395A (zh) | 含有地氯雷他定结构的氨基酸类衍生物、其制备方法和用途 | |
CN103664922A (zh) | 新晶型阿齐沙坦及其制备方法 | |
CN108586360B (zh) | 一种6-氯-3-甲基尿嘧啶的制备方法 | |
CN105801475B (zh) | 一种甲苯磺酸索拉非尼的制备方法 | |
CN105367470A (zh) | 一种维格列汀的制备方法 | |
CN111718332B (zh) | 2-取代吡唑氨基-4-取代氨基-5-嘧啶甲酰胺类化合物、组合物及其应用 | |
CN100537552C (zh) | 一种制备瑞格列奈的方法 | |
CN102030671B (zh) | 医药级美法仑及其盐酸一盐、二盐的制备方法 | |
CN103508932B (zh) | 糖尿病药物格列美脲的合成方法 | |
WO2014020381A1 (en) | Novel crystalline form of azilsartan medoxomil potassium | |
CN105523985A (zh) | 一种维格列汀的制备方法 | |
CN102241721A (zh) | 一种卡培他滨及其羟基衍生物中间体的制备方法 | |
US20240083873A1 (en) | Pyrimidine carboxamide compound and application thereof | |
CN102070604B (zh) | 一种伊马替尼游离碱的制备方法 | |
CN109810094B (zh) | 一种阿格列汀的制备方法 | |
CN114644640B (zh) | 一种嘧啶甲酰胺类化合物及其应用 | |
CN103288703B (zh) | Ⅱ型糖尿病药物格列美脲中间体苯磺酰胺的合成方法 | |
CN102850260A (zh) | 一种盐酸乐卡地平杂质的制备方法 | |
EP3246308A1 (en) | Method for producing aromatic amine compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Defeng Inventor after: Yan Bin Inventor after: Zhu Xiaofei Inventor after: Wang Bingcai Inventor after: Yu Jianjun Inventor before: Wang Defeng Inventor before: Zhu Xiaofei Inventor before: Wang Bingcai Inventor before: Yu Jianjun |
|
COR | Change of bibliographic data | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20171215 Address after: 065402 Langfang city of Hebei province Xianghe County ZTE Backstreet No. 11 Tin Yuet District Building 3 room 2201 unit 2 Patentee after: Jiang Shulin Address before: The Yangtze River town of Rugao city of Jiangsu province in 226500 in Nantong city (Rugao port) Yuejiang Road No. 28 Patentee before: Jiangsu Defeng Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151021 Termination date: 20190922 |